Home
Forms Library
Who has the ultimate responsibility for the administration dispensation of an investigational product at the clinical site

DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form. DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form 2026

who has the ultimate responsibility for the administration dispensation of an investigational product at the clinical site Preview on Page 1

See details

4.8 out of 5

260 votes

The document is an Investigational Product Accountability Record (Form G) used in clinical research to track the handling of investigational products, including details such as site information, product specifications, storage conditions, and inventory management. It includes sections for recording quantities dispensed, returned, destroyed, or transferred, along with comments on discrepancies and reasons for actions taken.

Here's how it works

01. Edit your who has the ultimate responsibility for the administration dispensation of an investigational product at the clinical site online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send accountability log template via email, link, or fax. You can also download it, export it or print it out.

How to use or fill out DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form with our platform

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Click ‘Get Form’ to open the DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form in the editor.
Begin by entering the Clinical Research Site Name and Number at the top of the form. This identifies where the investigational product is being managed.
Fill in the Investigator of Record Name and Protocol Number to ensure accountability and traceability for the study.
Input the Investigational Product Name, Strength and Dosage Form, and Package Size. These details are crucial for accurate tracking of the product.
Record the Date, Manufacturer, and Subject ID# (SID) to maintain a clear timeline and association with specific subjects.
Document Lot Number, Storage Temperature, and Expiration Date* if available. This information is vital for compliance with storage regulations.
In the Quantity section, indicate how much was Destroyed, Returned, Dispensed (-), or Inventory Transferred*. Provide reasons in Comments for any discrepancies or actions taken.
Finally, have a Pharmacist/Tech Initial next to your entries to validate accuracy before saving your completed form.

Start using our platform today to streamline your document editing and form completion process for free!

See more DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form. DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form versions

We've got more versions of the DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form. DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form form. Select the right DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form. DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form version from the list and start editing it straight away!

Versions	Form popularity	Fillable & printable
2016	4.8 Satisfied (260 Votes)

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

Who is responsible for IP accountability at a site?

The Investigator is accountable for IP Reconciliation at the site even if specific tasks are delegated. The reconciliation can either be conducted periodically or at the end of the study (as per Sponsors Standard Operating Procedures).

What is the investigational drug accountability record?

It lists many things about each drug, including the drug name, lot number, expiration date, the amount of drug received, used, returned, or thrown away, and the amount left. Drug Accountability Records help make sure that a clinical trial is done safely and correctly.

What is investigational product accountability?

Investigational Product Accountability: Includes documentation of the following on an ongoing basis: When drug supplies arrive. When a drug is dispensed. When a drug is returned by a subject. When a drug is returned to supplier or is destroyed.

What is a pharmacy manual in clinical trials?

A pharmacy manual is a comprehensive document provided by the trial sponsor or contract research organization (CRO). It outlines detailed instructions for the storage, preparation, dispensing, and accountability of study drugs.

What is IP accountability in clinical trials?

Being accountable for the IP includes, but is not limited to, documenting the conditions under which the test article was shipped, stored, administered, returned, and/or destroyed, along with any special labeling or quality control measures that may be required.

drug accountability log template

what is a pharmacy manual in clinical trials fda guidance on investigational product accountability investigational product accountability log template pharmacy manual template pharmacy manual clinical trial fda pharmacy manual fda drug dispensing in clinical trials investigational drug storage requirements

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more

Related forms

be ready to get more

Complete this form in 5 minutes or less

Get form

What is required for investigational product accountability?

Investigator Record Keeping and Retention 312.62(b) An investigator is required to prepare and maintain adequate and accurate case histories that record all observations and other data pertinent to the investigation on each individual administered the investigational drug or employed as a control in the investigation.

Who is responsible for IP accountability at a trial site?

General Responsibilities: It is the responsibility of the Principal Investigator (PI) at the site of a clinical trial to ensure accurate and complete accountability and proper storage of investigational drugs/products used in a clinical trial.

DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form. DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form 2026

Here's how it works

How to use or fill out DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form with our platform

See more DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form. DAIT Pharmacy Guidelines - Investigational Product Accountability Record Form versions

Complete this form in 5 minutes or less

Got questions?

Who is responsible for IP accountability at a site?

What is the investigational drug accountability record?

What is investigational product accountability?

What is a pharmacy manual in clinical trials?

What is IP accountability in clinical trials?

Security and compliance

Complete this form in 5 minutes or less

People also ask

What is required for investigational product accountability?

Who is responsible for IP accountability at a trial site?

who has the ultimate responsibility for the administration dispensation an investigational product at the clinical site

Try more PDF tools